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Abstract
Aims/hypothesis Foot ulceration is a serious complication for people with diabetes that results in high levels of morbidity for
individuals and significant costs for health and social care systems. Nineteen systematic reviews of preventative interventions
have been published, but none provides a reliable numerical summary of treatment effects. The aim of this study was to
systematically review the evidence from RCTs and, where possible, conduct meta-analyses to make the best possible use of
the currently available data.
Methods We conducted a systematic review and meta-analysis of RCTs of preventative interventions for foot ulceration. OVID
MEDLINE and EMBASE were searched to February 2019 and the Cochrane Central Register of Controlled Trials to October
2018. RCTs of interventions to prevent foot ulcers in people with diabetes who were free from foot ulceration at trial entry were
included. Two independent reviewers read the full-text articles and extracted data. The quality of trial reporting was assessed
using the Cochrane Risk of Bias tool. The primary outcome of foot ulceration was summarised using pooled relative risks in
meta-analyses.
Results Twenty-two RCTs of eight interventions were eligible for analysis. One trial of digital silicone devices (RR 0.07 [95%CI
0.01, 0.55]) and meta-analyses of dermal infrared thermometry (RR 0.41 [95% CI 0.19, 0.86]), complex interventions (RR 0.59
[95% CI 0.38, 0.90], and custom-made footwear and offloading insoles (RR 0.53 [95% CI 0.33, 0.85]) showed beneficial effects
for these interventions.
Conclusions/interpretation Four interventions were identified as being effective in preventing foot ulcers in people with diabetes,
but uncertainty remains about what works and who is most likely to benefit.
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Foot ulceration is a serious complication of diabetes
that can result in high levels of morbidity for individ-
uals and burdens health and social care systems with
huge costs [1, 2]. Predicting those people most likely to
develop a foot ulcer has been the subject of much
research and the independent risk factors have been
established [3, 4]. However, the value of prediction
models to inform treatment decisions depends on the
availability of effective interventions to modify risk [5].
As part of a wider research project to create a cost-
effective, evidence-based pathway for assessing and
managing the foot in diabetes, we conducted an over-
view of existing systematic reviews to synthesise the
available evidence on treatment effects (PROSPERO
registration: CRD42016052324). Although the overview
identified 19 published reviews [6–24], it failed to
provide reliable numerical summaries of effects because
of limitations of the reviews in scope, overlap and qual-
ity [25]. A comprehensive review of RCTs was required
to enable us to make the best possible use of the data
currently available and re-explore the possibility of
performing meta-analyses.
Methods
Our aim was to systematically review data from RCTs
of interventions used to prevent foot ulcerations in
diabetes, and to conduct meta-analyses to obtain pooled
estimates of their effects. We included data from RCTs
only, as this is the only method of clinical evaluation
that controls for known, unknown and unmeasured
confounding.
The protocol can be viewed at www.journalslibrary.nihr.ac.
uk/programmes/hta/1517101.
Eligibility criteria
Trials were permitted to include people of any age with
a diagnosis of type 1 or type 2 diabetes, with or with-
out a history of ulceration, but free from foot ulceration
at trial entry.
Simple interventions (e.g. education aimed at individ-
uals with diabetes or physicians, or the provision of
footwear) and complex interventions (where several
interventions were provided together) were eligible for




Primary outcomesWe were primarily interested in foot ulcers
(incident, primary and recurrent) reported as binary outcomes
(present/absent). These could be defined, for example, as ‘a
full-thickness skin defect that requires more than 14 days to
heal’ [26] or according to a system of ulcer classification [27].
Primary outcomes were the absolute numbers of incident
primary ulcers and of incident recurrent ulcers.
Secondary outcomes In reports where foot ulceration was
the primary outcome we also sought data on amputation
(minor: involving the foot [intrinsic to the foot]; or
major: involving the foot and leg); mortality; gangrene;
infection; adverse events; harms; time to ulceration;
quality of life (measured using the EuroQol five-
dimensions questionnaire or the six- or 12-item Short
Forms); timing of screening; self-care; hospital admis-
sions; psychological (knowledge/behaviour); and adher-
ence to therapy.
Searches
We searched OVIDMEDLINE (see electronic supplementary
material [ESM] Table 1) and OVIDEMBASE (from inception
to February 2019) and the Cochrane Central Register of
Controlled Trials (to October 2018) for eligible RCTs, without
language restrictions. ClinicalTrials.gov was searched for
ongoing clinical trials (search date: 21 February 2019).
Trial selection and data extraction
One reviewer screened all titles and abstracts and a 10%
random sample was checked by a second reviewer. Two
reviewers working independently screened full-text articles
and extracted data (D. J. Nicholson, and either F. Crawford
or A. E. Amanna) about the included populations, including
the risk classification, interventions, comparators and
outcomes. For each trial we extracted absolute numbers
on an intention-to-treat basis, where the numbers
randomised to each group were available, and calculated
RRs and 95% CIs. Where reports lacked information or clar-
ity, we contacted the trial authors. Non-English language
reports were translated.
Risk of bias (quality) assessment
We assessed the quality of trial reporting using the Cochrane
Risk of Bias tool [28]. The five domains we assessed were:
random sequence generation, allocation concealment,
blinding of assessors to the outcome, incomplete outcome
data and selective reporting [28]. We also noted whether an
a priori sample size calculation was reported [29].
Data analysis
Absolute numbers were extracted and RRs and 95% CIs were
calculated. Where it made clinical and statistical sense to pool
the data, we undertook meta-analyses with trial data weighted
according to the inverse variance method and assessed hetero-
geneity using the I2 statistic [28]. Analyses were conducted
using R version 3.4.2 (https://cran.r-project.org).
Results
From 10,488 studies, 22 RCTs met our eligibility criteria
[30–51]. A flow diagram showing the flow of information
throughout the process of screening and selecting studies for
inclusion in the review is presented in Fig. 1 and the charac-
teristics of the included trials are described in Table 1. Table 1
also incorporates the results from the risk of bias assessment;
only five of the 22 trials [36, 39, 42, 46, 50] were judged to be
at low risk of bias.
Overall, the included trials assessed eight different types of
interventions to prevent foot ulceration, which we grouped as
follows: (1) education alone (three trials) [34–36]; (2) dermal
infrared thermometry (four trials) [37–40]; (3) complex inter-
ventions (five trials) [41–45]; (4) custom-made footwear and
offloading insoles (six trials) [46–51]; (5) digital silicone
device (one trial) [32]; (6) antifungal treatment (one trial)
[30]; (7) elastic compression stockings (one trial) [31]; and
(8) podiatric care (one trial) [33].
Education alone
Three RCTs evaluated single-session education interventions
of varying length and content for people at high risk of foot
ulceration [34–36].
Meta-analysis (n = 423) (Fig. 2a) showed no statistically
significant difference in the incidence of foot ulceration at
6 months compared with standard care and advice (RR 1.04
[95% CI 0.54, 1.97]) [34–36]. The quality of the included
trials was variable, with only one trial [36] judged to be at
low risk of bias across all domains. Other sources of potential
bias arose from one trial [34] being stopped early and another
[35] reporting an interim analysis before target recruitment
was reached [52].
Secondary outcomes Two trials of education interventions
reported data on amputation [34, 36], mortality [34],
Diabetologia
knowledge [34], behaviour [36] and/or quality of life [36]. No
amputations were recorded for participants in either arm at
6 months’ follow-up in one trial [34]. The other trial reported
3/85 amputations in the intervention arm vs 0/85 in the control
arm at 6 months, and no difference (n = 9 in both arms) at
12 months [36].
One trial [34] reported that two participants, one in each
arm, had died by 6 months. In the same trial, a statistically
significant difference in knowledge (as measured by the
Patient Interpretation of Neuropathy knowledge score) was
observed in the intervention arm [34].
One trial [36] reported on quality of life and found no
differences between the two arms on the Diabetic Foot
Scale, but higher scores for those in the education arm on
the Nottingham Assessment of Functional Footcare question-
naire, which assesses behaviour, compared with the control
group.
Dermal infrared thermometry
Four RCTs involving 468 participants with diabetes were
identified [37–40]. In one trial [37], the numbers of partici-
pants randomised to either dermal infrared thermometry or
standard care were not known, and so an RR and 95% CI
could not be calculated.
Meta-analysisA pooled analysis of data from three RCTs (n =
243) [38–40] found that dermal infrared thermometry reduced
the number of foot ulcers in people with a history of foot
ulceration (RR 0.41 [95% CI 0.19, 0.86]) (Fig. 2b).
Outcomes were collected between 6 and 15months. The qual-
ity of these trials was variable, with only one trial [39] judged
to be at low risk of bias across all domains.
Secondary outcomes Trials of dermal thermometry variously
reported on amputation following infection [37], quality of
life (36-item Short Form [SF-36]) [37], adherence to therapy
[38, 39] and time to ulceration [39, 40].
In one trial, amputations following infections occurred in
0/41 participants in the intervention group vs 2/44 in the
comparator group [38]. In the same trial there was no statisti-
cally significant difference in quality of life measured using
SF-36 in any category or in the overall score [38].
Two trials [39, 40] found no statistically significant differ-
ence between the dermal thermometry group and the compar-
ator group in the time that prescribed footwear and insoles
were worn, as measured using a self-report questionnaire
containing an ordinal scale of <4 to >12 h/day. The time to
ulceration was statistically significantly longer in the dermal
thermometry treatment group compared with standard care in
one trial [39] but not in another [40].
Complex interventions
Five RCTs evaluated the effects of complex interventions (i.e.
integrated combinations of patient- or physician-level inter-
ventions and structural interventions) on the development of
a foot ulcer [41–45].
Full texts meeting inclusion 
criteria from systematic 
reviews (n=5)
Ongoing trials identified 
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Meta-analysis A pooled analysis of data from five RCTs (n =
2587) showed that complex interventions statistically signifi-
cantly reduced the number of foot ulcers (RR 0.59 [95% CI
0.38, 0.90]) at 1 or 2 year follow-up (Fig. 2c), with little
evidence of statistical heterogeneity (I2 = 10%; Fig. 2c)
despite the variety of interventions tested. However, with the
exception of one trial [42], all had a high risk of bias and the
validity of these data may be compromised. One trial gave no
information about the participants’ risk category [44], while
three included people with no history of foot ulceration
[41,43]. One trial included people who were at low/
moderate or high risk of developing a foot ulcer, found that
75% of ulcers occurred in people with higher levels of risk; for
the highest risk category (category 4), 2/6 individuals in the
intervention group and 2/3 individuals in the comparator
group developed foot ulcers [41].
None of the individual trial results reached statistical signif-
icance and only one [42] reported an a priori sample size
calculation; however, one trial [45] recruited everyone attend-
ing the foot care service.
Secondary outcomes Amputation [43, 45], time to ulceration
[41] and/or knowledge [43] were reported in three trials. In
one trial [43] amputations occurred only in the control arm
(2/31 vs 0/31 in the intervention arm), and in a second trial
[45] there were fewer amputations in the intervention group
(one major and six minor amputations) compared with the
control group (12 major and 13 minor) [45]. The time to
ulceration was shorter in the control group vs the intervention
group in one trial, but this did not reach statistical significance
[41].
In one trial participants’ knowledge about foot care, as
measured using a diabetes knowledge questionnaire, was
statistically significantly better in the intervention group
compared with the control group [43].
Custom-made footwear and offloading insoles
Six RCTs evaluated custom-made footwear and offloading
insoles [46–51].
Meta-analysis A pooled estimate of data from six trials
showed a beneficial association for custom-made footwear
and offloading insoles on reducing the development of foot
ulcers (pooled RR 0.53 [95% CI 0.33, 0.85]; Fig. 2d) for
outcomes collected at 12–24months in 1387 people, of whom
464 had no history of foot ulceration. There was evidence of
considerable statistical heterogeneity (I2 = 78%), which we
explored using baseline risk of ulceration in a subgroup
analysis (Fig. 3). This pooled analysis of four trials [46, 47,
50, 51], all of which excluded people with no history of foot
ulceration, failed to detect a statistically significant difference
(RR 0.71 [95% CI 0.47, 1.06]). The six trials were of variable
quality, with only two [46, 50] having a low risk of bias across
all five domains.
Secondary outcomes Adherence [46, 48, 49] and/or cost [48]
data were reported in four trials. One trial measured adherence
using a temperature-based monitor placed inside the shoe, and
found that 35/85 participants in the intervention group and 42/
86 in the control group adhered to wearing their allocated
footwear [46]. The trial authors conducted a subgroup analysis
in participants who wore their allocated footwear, which
showed a statistically greater reduction in ulcer recurrence in
the intervention group; however, the analysis using data from
the entire trial population failed to detect a beneficial associa-
tion. A second trial of custom-made footwear and offloading
insoles measured adherence using a self-reported physical
activity questionnaire, and found that footwear and insole
use was high in the groups who received cork inserts (83%)
and prefabricated insoles (86%) [47]. A third trial measured
participant compliance with footwear using self-reports of the
number of hours per day that the shoes were worn. There were
no statistically significant differences between each group in
the number of people who wore the shoes for less than 4 h per
day (23/149 vs 16/150), 4–8 h (77/149 vs 83/150), 8–12 h (38/
149 vs 46/150) and 12–16 h (10/149 vs 6/150) [49].
Cost data collected in one trial published in 2012 found the
cost of supplying footwear and insoles to be €675 per person
per year [48].
Digital silicone devices
In one RCT of digital silicone devices [32], 167 participants
with peripheral neuropathy, as defined by a vibration percep-
tion threshold of >25 V measured using a biothesiometer, and
toe deformities (clawed toes, hallux valgus, interdigital
lesions) were randomised to receive a bespoke silicone digital
orthotic (n = 89) or standard care (n = 78). The number of
ulcers was statistically significantly lower in the intervention
group (RR 0.07 [95% CI 0.01, 0.55]) at 3 month follow-up.
This trial had a low risk of bias in all domains except for
allocation concealment, which was unclear.
Antifungal treatment
In a trial of antifungal nail lacquer, participants in the inter-
vention group (n = 34) received advice to inspect their feet
daily and apply ciclopirox 8% to their toenails [30]. The
control group (n = 36) received advice about daily foot inspec-
tions. A history of foot ulcers was reported by 57% of partic-
ipants. After 12 months there were two ulcerations in each
Fig. 2 Forest plots of foot ulcers in people receiving standard care vs (a)
education alone, (b) dermal infrared thermometry, (c) complex
interventions and (d) custom-made footwear and offloading
Diabetologia
group (RR 1.06 [95% CI 0.19, 5.76]). The risk of bias was
unclear in two domains: allocation concealment and blinding
of the outcome assessor.
Elastic compression stockings
An RCT of elastic stockings randomly allocated 160
people with no history of foot ulceration to either
knee-length elastic stockings worn for 6 h/day or stan-
dard care [31]. There were three ulcers in the interven-
tion group and ten in the control group, a difference
that was not statistically significant (RR 0.37 [95% CI
0.11, 1.02]). The trial had a high or unclear risk of bias
in the domains of sequence generation, allocation
concealment and assessor blinding.
Secondary outcomes Thirteen limbs were reported as lost
during the 48 month trial; 3/74 in the intervention arm and
10/75 in the control arm.
Podiatric care
One trial compared free chiropody care (n = 47) with no
chiropody care (n = 44) for people all at high risk of foot
ulceration [33]. Those receiving free chiropody were recom-
mended to seek care at least once per month. The control
group could seek chiropody if they were willing to pay for
it, and their standard care included advice on the possible
benefits of regular chiropody. There was no statistically signif-
icant difference in the number of ulcerations in the two groups
(RR 0.67 [95%CI 0.43, 1.05]). This trial had a low risk of bias
in all domains except assessor blinding to outcome data,
which was unclear.
Secondary outcomes There were 2/47 amputations in the
intervention arm vs 1/44 in the control arm. Deaths were
recorded as 2/47 in the intervention arm vs 4/44 in the control
arm [33].
Data for other secondary outcomes of interest, such as
gangrene, self-care, hospital admissions, timing of screening
and adverse events or harms, were absent from the trial
reports.
Ongoing trials
The search for ongoing trials of foot ulcer prevention in diabe-
tes from the ClinicalTrials.gov website found 24 studies being
conducted worldwide. The stated interventions in these
studies are: physiotherapy (n = 1), skin temperature (n = 6),
hygiene (n = 1), offloading insoles (n = 10), risk stratification
(n = 2), PET-CT (n = 1), amniotic tissue (n = 1) and unclear
(n = 2). The list of these studies can be obtained from the
corresponding author.
Discussion
The purpose of this systematic review was to evaluate the
evidence base and obtain summary statistics for preventative
interventions for foot ulceration in diabetes to create a cost-
effective, evidence-based care pathway. The meta-analyses of
dermal infrared thermometry, complex interventions and ther-
apeutic footwear with offloading insoles suggest that these
interventions can help prevent foot ulceration in people with
diabetes.
The meta-analysis of data from RCTs of dermal infrared
thermometry in people with a history of foot ulceration and a
Bus et al (2013) [46]
Rieber et al (2002) [47]
Uccioli et al (1995) [51]
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Fig. 3 Subgroup analysis. Forest plot of foot ulcers in people with a history of foot ulceration receiving custom-made footwear and offloading vs
standard care
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moderate to high risk of ulceration indicates that this is a
promising intervention deserving of further evaluation in
randomised trials with larger participant samples, and we note
from our search of the ClinicalTrials.gov trial registry that new
trials are currently underway. If foot ulcer prevention can be
confirmed in large, well-conducted trials, this form of self-
monitoring could relieve pressure on healthcare systems.
However, advising individuals to abstain from all weight-
bearing activities when foot temperatures rise by more than
4°C may prove challenging, and poor adherence might dimin-
ish any benefit in a real-world context outside of a trial setting.
Specialist foot care, of the type evaluated in the included
trials of complex interventions, is considered a marker of
good-quality diabetes service delivery and it is intuitively
correct to suppose it leads to improved outcomes. While a
statistically significant reduction in foot ulcers was apparent
in our meta-analysis, such an effect was not evident in any
single trial. This does support the suggestion of others that
very large sample sizes may be needed for trials of this nature
[53]. Surprisingly, there was a low level of statistical hetero-
geneity in the pooled data, despite quite marked differences in
the clinical care provided in the intervention arms of the trials
and the participation of people with three different levels of
ulcer risk.
Our review did not identify any trials of complex interven-
tions that reflect the composition of multidisciplinary foot
services as recommended in clinical guidelines [54–56].
These influential documents advise the involvement of diabe-
tologists, podiatrists, vascular surgeons, diabetes specialist
nurses and orthotists as the core team in a diabetes foot care
service, but patient outcomes from such healthcare service
arrangements have not been evaluated in RCTs. An evaluation
of outcomes from people at different levels of ulceration risk
who receive care in specialist foot care settings would be
worthwhile.
The true value of therapeutic footwear and offloading
insoles in preventing foot ulcers has been obscured by contra-
dictory trial results and poor interpretation of data in system-
atic reviews; two larger trials involving only those with a
history of foot ulcers both failed to detect evidence of effec-
tiveness [46, 47], and visual inspection of our analyses of
pooled data from all six trials shows greatest beneficial effect
in those where the majority of participants were considered to
be at high or moderate risk but had not experienced a foot
ulcer [48, 49], albeit only one reached statistical significance
[48]. Our subgroup analysis of data from four trials of partic-
ipants with a history of foot ulceration found no statistically
significant difference in the number of recurrent ulcers
between the custom footwear and control groups.
This observation calls into question the conclusions of
other systematic reviews evaluating footwear and insoles in
the prevention of foot ulcers [6, 17, 24]. The most recent
included randomised and non-randomised data and adopted
a consensus approach to the analysis. The reviewers conclud-
ed that: ‘The evidence base to support the use of specific self-
management and footwear interventions for the prevention of
recurrent plantar foot ulcers is quite strong, but…is practically
non-existent for the prevention of a first foot ulcer and non-
plantar foot ulcer’ [24]. An individual participant data analysis
using data from these six trials together with data from the ten
ongoing studies of offloading insoles identified by our search
of the ClinicalTrials.gov database could permit subgroup
analyses to explore the value of footwear and offloading
insoles in people with different baseline risks, and
potentially resolve these ongoing uncertainties.
The marked reduction in ulcerations reported with the use
of a dermal silicone device by individuals at high risk of ulcer-
ation is encouraging [32]. These devices are simple to make at
the chair-side and easy for wearers to keep clean. Although
they are a type of offloading intervention, we did not include
these data in the meta-analysis of footwear and offloading
insoles because they differ substantially in that they are only
worn around the toes.
Three separate small trials [30, 31, 33] evaluating, respec-
tively, the effects of a daily application of a fungal nail lacquer
(ciclopirox 8%) with daily foot inspections, the use of elastic
compression stockings and podiatry all failed to show a reduc-
tion in foot ulcers, possibly as a result of small sample sizes.
Strengths and limitations of this review We have comprehen-
sively reviewed a body of evidence from RCTs and made the
fullest use of the data currently available to derive best estimates
of treatment effects to inform a wider piece of work. In so doing
we have highlighted uncertainties, gaps and limitations in the
existing evidence base to informpractice, generated new research
hypotheses and added value to this area of research.
The weaknesses of this review arise from the potential biases
identified in many of the trial reports, especially for complex
interventions, which may have produced unreliable results.
Previous authors of systematic reviews have cited a lack of simi-
larity between studies [13], lack of standardisation in terminolo-
gy, prescription, manufacture and material properties of interven-
tions [16], heterogeneity in study designs, methodology and
participant populations [18], and differences in participant demo-
graphics [22] as reasons for not conducting meta-analyses, and
we are aware of the potential limitations in the pooled analyses
that we present here, both in the number and quality of trials. We
have tried to produce conservative, less biased summary
measures by adopting an intention-to-treat approach and a
random-effects model. We acknowledge criticisms about the
use of the latter [57], but believe the insights gleaned and the
generation of new research hypotheses justifies our decision to
pool data [58].
ConclusionsOur analyses found evidence of beneficial effects
for four types of interventions used to prevent foot ulcers in
Diabetologia
people with diabetes, but considerable uncertainty remains
about what works and who is most likely to benefit.
Attention should be given to recommendations for the conduct
of trials of interventions for the foot in diabetes, and
researchers conducting future trials should endeavour to
complete the trial to target recruitment as informed by an a
priori sample size calculation [29, 59].
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